Our primary focus is on the advancement and commercialization of innovative antimicrobial treatments that cater to important patient requirements, are eco-friendly, offer significant public health advantages, are easily deployable, and are cost-effective compared to the infections they combat. Taking the lead in pioneering photodisinfection-based therapies to prevent and manage a wide range of infections, including those induced by drug-resistant bacteria.